| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |